Microbiome-targeted antibiotics provide no additional microbiologic or inflammatory benefit during cystic fibrosis pulmonary exacerbations: results from the CFMATTERS trial

Gisli G Einarsson, Andrew J Lee, Zina Alfahl, Lauren Kerrigan, Joseph A Eustace, Sinéad Weldon, Barry J Plant, J Stuart Elborn, Clifford C Taggart, Marcus A Mall, Michael M Tunney · 2026

Read Microbiome-targeted antibiotics provide no additional microbiologic or inflammatory benefit during cystic fibrosis pulmonary exacerbations: results from the CFMATTERS trial by Gisli G Einarsson, Andrew J Lee, Zina Alfahl, Lauren Kerrigan, Joseph A Eustace, Sinéad Weldon, Barry J Plant, J Stuart Elborn, Clifford C Taggart, Marcus A Mall, Michael M Tunney (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13624781.txt.

Description

Gisli G Einarsson and colleagues write to the editor with deeper results from the CFMATTERS trial in cystic fibrosis. During lung flare-ups, patients usually get two intravenous antibiotics, and the trial added a third drug chosen from gene-sequencing profiles of each patient's sputum germs. The main trial had already shown no clinical gain, so the team asked whether the extra drug at least cut germ levels or airway inflammation further.

Sputum gathered before treatment, at its start, and on day fourteen showed no extra drop in microbe measures or inflammation markers from the added drug. The usual pair did the measurable work. The letter tempers hopes that sequencing-guided add-ons help during flare-ups, at least with the drugs and timing this trial used.

Catalog record

CREATORGisli G Einarsson, Andrew J Lee, Zina Alfahl, Lauren Kerrigan, Joseph A Eustace, Sinéad Weldon, Barry J Plant, J Stuart Elborn, Clifford C Taggart, Marcus A Mall, Michael M Tunney
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE10 KB
LICENSEhttps://creativecommons.org/licenses/by/4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/article/MED/PMC13624781

Browse the full library · About the Tower of Babel